A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-γ transactivation

Nature Cell Biology

Volumn 9, Issue 11, 2007, Pages 1273-1285

  Takada, Ichiro ^a   Mihara, Masatomo ^a,c   Suzawa, Miyuki ^a   Ohtake, Fumiaki ^a,b   Kobayashi, Shinji ^a,b   Igarashi, Mamoru ^a   Youn, Min Young ^a   Takeyama, Ken Ichi ^a   Nakamura, Takashi ^a,b   Mezaki, Yoshihiro ^a   Takezawa, Shinichiro ^a   Yogiashi, Yoshiko ^a   Kitagawa, Hirochika ^a   Yamada, Gen ^d   Takada, Shinji ^e   Minami, Yasuhiro ^f   Shibuya, Hiroshi ^g   Matsumoto, Kunihiro ^h   Kato, Shigeaki ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

^d KUMAMOTO UNIVERSITY   (Japan)

^e OKAZAKI INSTITUTE FOR INTEGRATIVE BIOSCIENCE   (Japan)

^f KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^h NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; HISTONE LYSINE METHYLTRANSFERASE; HISTONE METHYLTRANSFERASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; NEMO LIKE KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; UNCLASSIFIED DRUG; WNT PROTEIN; WNT5A PROTEIN;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CHROMATIN; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME SYNTHESIS; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METHYLATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

ADIPOGENESIS; ANIMALS; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DOWN-REGULATION; GENETIC VECTORS; HISTONE-LYSINE N-METHYLTRANSFERASE; MICE; MICE, TRANSGENIC; MUTATION; OSTEOGENESIS; PHOSPHORYLATION; PLASMIDS; PPAR GAMMA; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); WNT PROTEINS;

EID: 35748960839     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb1647     Document Type: Article

References (50)

1. Fischle, W., Wang, Y. & Allis, C.D. Histone and chromatin cross-talk. Curr. Opin. Cell Biol. 15, 172-188 (2003).
2. Margueron, R., Trojer, P. & Reinberg, D. The key to development: interpreting the histone code? Curr. Opin. Genet. Dev. 15, 163-176 (2005).
3. Martin, C. & Zhang, Y. The diverse functions of histone lysine methylation. Nature Rev. Mol. Cell Biol. 6, 838-849 (2005).
4. Bannister, A. J. & Kouzarides, T. Reversing histone methylation. Nature 436, 1103-1106 (2005).
5. Metzger, E., Wissmann, M. & Schule, R. Histone demethylation and androgen-dependent transcription. Curr. Opin. Genet. Dev. 16 513-517 (2006).
6. Wu, R. C., Smith, C. L. & O'Malley, B. W. Transcriptional regulation by steroid receptor coactivator phosphorylation. Endocr. Rev. 26 393-399 (2005).
7. Dilworth, F. J. & Chambon, P. Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription. Oncogene 20, 3047-3054 (2001).
8. Rosenfeld, M. G., Lunyak, V. V. & Glass, C., K. Sensors and signals: A coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev. 20, 1405-1428 (2006).
9. Pascual, G. et al. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature 437, 759-763 (2005).
10. Evans, R. M., Barish, G. D. & Wang, Y. X. PPARs and the complex journey to obesity. Nature Med. 10, 355-361 (2004).
11. Feige, J. N., Gelman, L., Michalik, L., Desvergne, B. & Wahli, W. From molecular action to physiological outputs. peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Prog. Lipid Res. 45, 120-159 (2006).
12. Lehrke, M. & Lazar, M. A. The many faces of PPARgamma. Cell 123 993-999 (2005).
13. Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I. & Spiegelman, B. M. mPPAR gamma 2: Tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8, 1224-1234 (1994).
14. Hu, E., Kim, J. B., Sarraf, P. & Spiegelman, B. M. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. Science 274, 2100-2103 (1996).
15. Suzawa, M. et al. Cytokines suppress adipogenesis and PPAR-gamma function through the TAK1/TAB1/NIK cascade. Nature Cell Biol. 5 224-230 (2003).
16. Chien, K. R. & Karsenty, G. Longevity and lineages toward the integrative biology of degenerative diseases in heart, muscle, and bone. Cell 120, 533-544 (2005).
17. Harada, S. & Rodan, G. A. Control of osteoblast function and regulation of bone mass. Nature 423, 349-355 (2003).
18. Ralston, S. H. & de Crombrugghe, B. Genetic regulation of bone mass and susceptibility to osteoporosis. Genes Dev. 20, 2492-2506 (2006).
19. Behrens, J. et al. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382, 638-642 (1996).
20. Ishitani, T. et al. The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/ beta-catenin signaling. Mol. Cell. Biol. 23, 131-139 (2003).
21. Veeman, M. T., Axelrod, J. D. & Moon, R. T. A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. Dev. Cell 5, 367-377 (2003).
22. Schultz, D. C., Ayyanathan, K., Negorev, D., Maul, G. G. & Rauscher, F. J. 3rd. SETDB1: A novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev. 16 919-932 (2002).
23. Wang, H. et al. mAM facilitates conversion by ESET of dimethyl to trimethyl lysine 9 of histone H3 to cause transcriptional repression. Mol. Cell 12, 475-487 (2003).
24. Vissers, L. E. et al. Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nature Genet. 36, 955-957 (2004).
25. Komatsu, Y. et al. Targeted disruption of the Tab1 gene causes embryonic lethality and defects in cardiovascular and lung morphogenesis. Mech. Dev. 119, 239-249 (2002).
26. Ishitani, T. et al. The TAK1-NLK-MAPK-related pathway antagonizes signalling between beta-catenin and transcription factor TCF. Nature 399, 798-802 (1999).
27. Almind, K. & Kahn, C. R. Genetic determinants of energy expenditure and insulin resistance in diet-induced obesity in mice. Diabetes 53 3274-3285 (2004).
28. Mueller, E. et al. Terminal differentiation of human breast cancer through PPAR gamma. Mol. Cell 1, 465-470 (1998).
29. Hong, J. H. et al. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 309, 1074-1078 (2005).
30. Schwartz, A. V. et al. Thiazolidinedione use and bone loss in older diabetic adults. J. Clin. Endocrinol. Metab. 91, 3349-3354 (2006).
31. Akune, T. et al. PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J. Clin. Invest. 113, 846-855 (2004).
32. Takada, S. et al. Wnt-3a regulates somite and tailbud formation in the mouse embryo. Genes Dev. 8, 174-189 (1994).
33. Glass, D. A. 2nd et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev. Cell 8 751-764 (2005).
34. Gong, Y. et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107, 513-523 (2001).
35. Ross, S. E. et al. Inhibition of adipogenesis by Wnt signaling. Science 289, 950-953 (2000).
36. Yamaguchi, T. P., Bradley, A., McMahon, A. P. & Jones, S. A Wnt5a pathway underlies outgrowth of multiple structures in the vertebrate embryo. Development 126, 1211-1223 (1999).
37. Kitagawa, H. et al. The chromatin-remodeling complex WINAC targets a nuclear receptor to promoters and is impaired in Williams syndrome. Cell 113, 905-917 (2003).
38. Yanagisawa, J. et al. Nuclear receptor function requires a TFTC-type histone acetyl transferase complex. Mol. Cell 9, 553-562 (2002).
39. Brehm, A., Tufteland, K. R., Aasland, R. & Becker, P. B. The many colours of chromodomains. Bioessays 26, 133-140 (2004).
40. Botrugno, O. A. et al. Synergy between LRH-1 and beta-catenin induces G1 cyclin-mediated cell proliferation. Mol. Cell 15, 499-509 (2004).
41. Kouzmenko, A. P. et al. Wnt/beta-catenin and estrogen signaling converge in vivo. J. Biol. Chem. 279, 40255-40258 (2004).
42. Asahina, M., Valenta, T., Silhankova, M., Korinek, V. & Jindra, M. Crosstalk between a nuclear receptor and beta-catenin signaling decides cell fates in the C. elegans somatic gonad. Dev. Cell 11 203-211 (2006).
43. Zhu, P. et al. Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepressibn pathway. Cell 124 615-629 (2006).
44. Garcia-Bassets, I. et al. Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors. Cell 128, 505-518 (2007).
45. Wang, J. et al. Opposing LSD1 complexes function in developmental gene activation and repression programmes. Nature 446, 882-887 (2007).
46. Kurahashi, T., Nomura, T., Kanei-Ishii, C., Shinkai, Y. & Ishii, S. The Wnt-NLK signaling pathway inhibits A-Myb activity by inhibiting the association with coactivator CBP and methylating histone H3. Mol. Biol. Cell 16, 4705-4713 (2005).
47. Kubota, N. et al. PPAR gamma mediates high-fat diet induced adipocyte hypertrophy and insulin resistance. Mol. Cell 4, 597-609 (1999).
48. Ohtake, F. et al. Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature 423, 545-550 (2003).
49. Fujiwara, M. et al. Isolation and characterization of the distal promoter region of mouse Cbfa 1. Biochim. Biophys. Acta 1446 265-272 (1999).
50. Fujiki, R. et al. Ligand-induced transrepression by VDR through association of WSTF with acetylated histones. EMBO J. 24, 3881-3894 (2005).